Atlas Trials

Study of Arimoclomol in Inclusion Body Myositis (IBM)

Clinical trial NCT02753530 · COMPLETED

Trial details

NCT number
NCT02753530
Sponsor
ZevraDenmark
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Inclusion Body Myositis
Start date
2017-08-16
Primary completion
2021-01-11
Enrollment
152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.